Day One, November 20, 2024 - ET (Eastern Time, GMT-05:00)
Day One, November 20, 2024 - ET (Eastern Time, GMT-05:00)
- Callie Mertel - Conference Producer, Informa Connect
- Jeff Park - Senior Director, Patient Support Services, Cytokinetics
Is AI just hype or the key to unlocking the future of patient support? During this session, cut through the noise and strategize on the best practices in leveraging AI.
- Personalize the patient journey at scale for improved engagement and adherence
- Predict and proactively address patient needs through data-driven insights
- Optimize resource allocation and streamline program operations
- Drive innovation in patient support services and stay ahead of the curve
- Alex Buell - Lead Director, Sales and Business Development, Cardinal Health™ Sonexus™ Access and Patient Support
- Allison Furniss - Director, Sales and Business Development, Cardinal Health™ Sonexus™ Access and Patient Support
This session delves into the latest trends and benchmarks in patient support models, providing a perspective of the benefits and challenges associated with each type. Attendees gain valuable insights into best practices for building, optimizing and seamlessly integrating their patient support models.
- Current trends and best practices in PSP operating models
- Evaluating operating models for benefits and challenges
- Assess strategic decisions for insourcing vs. outsourcing PSP components
- Leveraging specialized providers through enhanced PSP integration
- Josh Konetzni - Vice President, Head of Business Development, VMS BioMarketing
- Patrick Gomez Menzies - Director, Market Access, Chiesi USA, Inc.
- Geoff Fischer - Senior Manager, Specialty Access Solutions, GSK
As the patient support landscape continues to evolve so do the regulatory requirements and level of oversight around programs. Hear directly from enforcement agents regarding top trends, focal points and priorities for patient support programs in 2024 and beyond.
- Richard Liner - Senior Assistant General Counsel, Bayer
- Steven Sharobem - Assistant United States Attorney, US Attorney’s Office, District of Massachusetts
As the intricacies surrounding patient access become more complex, so have the compliance challenges faced by manufacturers.
- Discuss what is top of mind on compliance’s radar and why it should also be on yours
- Understand the importance of robust data and an effective vendor partnership in remaining compliant
- Learn the necessity behind compliance, marketing and commercial teams working together to conduct due diligence on your hub and the specific activities that are involved in doing so
- Navigate evolving regulations and enforcement activity with new patient access-related needs to mitigate risk and remain compliant
- Tara Kennedy - Global Director, Ethics & Compliance, Apellis Pharmaceuticals
- Donna White - Vice President, Compliance Officer, Chiesi USA Inc.
- Jonathan Amar - Assistant General Counsel, Sanofi
With field teams on the front lines, it is crucial for organizations to empower their FRMs and sales teams whilst also mitigating compliance risk.
- Uncover best practices in training and monitoring activities, including sensitivity training, whilst remaining compliant
- Discover strategies for field teams to convey program value whilst also being mindful of selling and/or medical language
- Examine how field teams work across the organization, including interactions and rules of engagement for FRMs and the importance of being proactive vs. reactive
- Delve into key areas of concern, including script usage, medical reporting boundaries and compensation nuances
- Debbie Walters - Vice President, Assistant General Counsel, Pfizer
Typically dominated by specialty therapeutics, the patient services industry is noticing an uptake in programs for retail therapies as well. Manufacturers must rethink how to operationalize their programs on a different scale to meet these patients’ needs. During this session, uncover the best path forward to serve retail patients and identify the key differences and challenges in your specialty vs. retail programs.
- Erica Devine - Associate Director, Patient Experience Strategy and Support, Otsuka
- Meghan Szczech, MBA - Executive Director, Patient Services and Trade, SK Life Science Inc
When building out a suite of services, organizations want to ensure that they are here to stay. In order to do so, programs need to be able to pivot and be flexible with the everchanging marketplace.
- Uncover the best practices in monitoring patient programs, including your hub, throughout their lifecycle
- Discuss the harms of remaining static, the benefits that both patients and providers derive from an agile program and how smooth communication can help achieve that
- Suzanne Marinakos - Director, Patient Services Operations, Novo Nordisk
- Explore fraud detection tools to unmask sophisticated schemes and protect resources
- Learn how to proactively identify suspicious activity, before it impacts programs, through data analytics
- Build a robust company compliance culture to deter fraud from within and strengthen program integrity
- Emphasize the importance of collaboration with key stakeholders, such as vendors and specialty pharmacies, to work together to create a more secure patient support ecosystem
Achieving impactful patient support programs requires seamless collaboration between access, legal/compliance, and patient support teams. Benchmark on best practices with colleagues to foster a collaborative and mutually beneficial environment that works toward the common goal of helping the patient.
Rare disease patients face a multitude of challenges, two of which include limited treatment options and a lack of dedicated and holistic support. This session tackles both, empowering industry leaders to create high-touch patient support programs to truly optimize patient outcomes.
- Learn innovative strategies to connect with and educate rare disease patients about available resources, even in the absence of approved therapies
- Explore effective methods for establishing trust and fostering long-term relationships. Discover partnerships, such as with patient advocacy organizations, to collaborate with
- Strategize on building programs that specifically cater to the needs of rare disease populations
- Liz Turner - Vice President, Global Market Access, Mirum Pharmaceuticals, Inc.
End your day with a personal development summit, hearing real-life experiences of colleagues’ successes, challenges, and individual experiences in creating a more inclusive culture within the patient support sector.
- Understand the correlation between health and financial literacy and patient adherence and engagement
- Benchmark with colleagues on how to revitalize your patient education material to address cultural misconception and/or mistrust and raise awareness surrounding clinical trials
- Brainstorm innovative solutions that manufacturers can utilize to better partner with patient advocacy groups
- Emily Gibb - Vice President, Head of Novartis Patient Support Cardiovascular, Renal, and Metabolic, Novartis